Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.
- 1 July 1987
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 50 (7) , 929-932
- https://doi.org/10.1136/jnnp.50.7.929
Abstract
Arginine-vasopressin (AVP) concentrations in five cortical areas were measured post mortem in nine patients with senile dementia of Alzheimer''s type (SDAT), and compared with the control group of comparable ages. In SDAT patients, AVP was significantly reduced in Brodmann areas 4, 7 and 10 (p < 0.05). In areas 17 and 22, the detectability and the mean concentrations of AVP were also lower than those of control patients, although not significantly.This publication has 26 references indexed in Scilit:
- CSF and plasma vasopressin concentrations in dementia.Journal of Neurology, Neurosurgery & Psychiatry, 1983
- Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalisAnnals of Neurology, 1981
- Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer typeLife Sciences, 1981
- Effects of Vasopressin on Human Memory FunctionsScience, 1981
- ARGININE VASOPRESSIN AND CHOLINE ACETYLTRANSFERASE IN BRAINS OF PATIENTS WITH ALZHEIMER TYPE SENILE DEMENTIAThe Lancet, 1980
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980
- Vasopressin content of rat brainLife Sciences, 1980
- Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer TypeThe British Journal of Psychiatry, 1979
- The influence of the posterior and inter-mediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in ratsInternational Journal of Neuropharmacology, 1965
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962